Establishment Labs Holdings (ESTA) Consolidated Net Income (2017 - 2026)
Establishment Labs Holdings (ESTA) posted quarterly Consolidated Net Income of -$13.4 million for Q1 2026, up 35.38% year-over-year from -$9.9 million in Q1 2025, and down 411.74% quarter-over-quarter from -$2.6 million in Q4 2025.
Establishment Labs Holdings (ESTA) Consolidated Net Income (2017 - 2026) Analysis & Trends
Establishment Labs Holdings' Consolidated Net Income history runs 10 years deep, the most recent figure standing at -$13.4 million for Q1 2026.
- In Q1 2026, Consolidated Net Income rose 35.38% year-over-year to -$13.4 million; the TTM figure through Mar 2026 stood at -$43.7 million (up 50.92% YoY), while the FY2025 annual figure was -$51.1 million, up 39.64% from the prior year.
- Consolidated Net Income for Q1 2026 stood at -$13.4 million, down from -$2.6 million in the prior quarter.
- The five-year high for Consolidated Net Income was -$2.6 million in Q4 2025, with the low at -$37.1 million in Q2 2022.
- The 5-year median for Consolidated Net Income is -$16.7 million (2024), against an average of -$17.8 million.
- The sharpest annual moves came in 2022 and 2025: Consolidated Net Income plunged 597.22% in 2022, then soared 92.43% in 2025.
- Establishment Labs Holdings' Consolidated Net Income stood at -$13.6 million in 2022, then sank by 51.47% to -$20.5 million in 2023, then slumped by 68.1% to -$34.5 million in 2024, then jumped by 92.43% to -$2.6 million in 2025, then plunged by 411.74% to -$13.4 million in 2026.
- Business Quant data shows ESTA's Consolidated Net Income at -$13.4 million in Q1 2026, -$2.6 million in Q4 2025, and -$11.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Consol Net Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.07 Bn | 193.46 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Stryker | 127.90 Bn | 124.43 Bn | 4.50 Bn | 1.28 Bn |
| 3 | Medtronic | 118.84 Bn | 109.62 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 73.33 Bn | 72.79 Bn | 3.85 Bn | 905.00 Mn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | 241.40 Mn |
| 6 | Dexcom | 34.46 Bn | 32.51 Bn | 830.00 Mn | 249.10 Mn |
| 7 | GE HealthCare Technologies | 33.91 Bn | 31.81 Bn | 2.18 Bn | 574.00 Mn |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | 1.04 Bn |
| 9 | Steris | 23.12 Bn | 22.64 Bn | 684.20 Mn | 201.00 Mn |
| 10 | Establishment Labs Holdings | 2.15 Bn | 2.08 Bn | 47.71 Mn | -11.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -11.75 Mn |
| Mar 31, 2026 | -13.38 Mn |
| Dec 31, 2025 | -2.62 Mn |
| Sep 30, 2025 | -11.15 Mn |
| Jun 30, 2025 | -16.59 Mn |
| Mar 31, 2025 | -20.71 Mn |
| Dec 31, 2024 | -34.53 Mn |
| Sep 30, 2024 | -16.68 Mn |
| Jun 30, 2024 | -17.18 Mn |
| Mar 31, 2024 | -16.20 Mn |
| Dec 31, 2023 | -20.54 Mn |
| Sep 30, 2023 | -29.27 Mn |
| Jun 30, 2023 | -16.75 Mn |
| Mar 31, 2023 | -11.94 Mn |
| Dec 31, 2022 | -13.56 Mn |
| Sep 30, 2022 | -18.61 Mn |
| Jun 30, 2022 | -37.11 Mn |
| Mar 31, 2022 | -5.93 Mn |
| Dec 31, 2021 | -14.19 Mn |
| Sep 30, 2021 | -14.68 Mn |